Title: Phase II Capital: Managing the Burn Rate with Something to Show for it
Abstract: 'It's the CEO's job to do a lot of the talking to the investors and the analysts. The Chief Executive of a biotechnology company has to be quite a good PR person, a good communicator for the organisation. Here, anybody who can't be a good communicator is going to lose credibility in their organisation. I would say if you can't communicate effectively with your outside constituencies, you're going to lose.KeywordsBurn RateVenture CapitalBiotech CompanyVenture Capital FinancingVenture Capital FirmThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Publication Year: 1992
Publication Date: 1992-01-01
Language: en
Type: book-chapter
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot